Last 36 quarters of trend data · Healthcare · Immunology Biotech
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.63 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 9999.00 | 126063.40 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.68 | 2.38 | 2.51 | 3.19 | 2.50 | 2.71 | 1.58 | 0.85 | 0.79 | 0.81 | 0.67 | 0.85 | 0.66 | 0.50 | 1.00 | 0.43 | 1.82 | 1.30 | 1.16 | 2.10 | 1.49 |
| — | -12.4% | +58.3% | +276.4% | +215.0% | +234.7% | +136.4% | -0.7% | +20.8% | +60.8% | -32.8% | +98.0% | -64.0% | -61.3% | -14.1% | -79.5% | +22.3% | -38.9% | -49.3% | +20.5% | -76.4% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | 100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | -7226694.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | -7654837.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -191.4% | -34.3% | -62.0% | -52.2% | -37.4% | -45.7% | -20.7% | -37.7% | -33.2% | -25.3% | -19.0% | -27.4% | -17.0% | -20.4% | -17.2% | -25.7% | -50.7% | -26.7% | -28.0% | -28.9% | -30.0% |
| — | +24.9% | -200.1% | -38.4% | -12.7% | -80.4% | -8.7% | -37.7% | -95.2% | -24.2% | -10.7% | -6.6% | +66.5% | +23.5% | +38.7% | +11.2% | -69.1% | -21.0% | -56.2% | +16.5% | -98.4% | |
| ROA | -162.8% | -29.4% | -50.5% | -40.8% | -31.9% | -42.4% | -19.6% | -34.6% | -29.7% | -23.3% | -17.6% | -25.3% | -15.2% | -17.4% | -14.8% | -21.6% | -41.8% | -23.9% | -25.3% | -25.8% | -26.6% |
| — | +30.8% | -158.0% | -17.8% | -7.3% | -82.5% | -11.1% | -37.0% | -95.1% | -33.7% | -19.4% | -17.1% | +63.5% | +27.2% | +41.6% | +16.3% | -57.1% | -20.3% | -50.5% | +20.6% | -96.7% | |
| ROIC | — | -221.0% | -1358.6% | -17162.1% | -1274.8% | -533.2% | -329.4% | -4258.9% | — | — | -5478.5% | — | — | — | — | — | — | — | -245.0% | -140.1% | -225.9% |
| — | +58.6% | -312.5% | -303.0% | — | — | +94.0% | — | — | — | — | — | — | — | — | — | — | — | +30.1% | +41.7% | -513.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | — | — | — | — | — | — | — | — |
| — | — | — | — | -79.6% | -63.4% | -50.3% | -59.4% | -21.9% | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.72 | 5.55 | 6.20 | 3.39 | 4.68 | 8.81 | 27.57 | 15.08 | 9.20 | 10.16 | 14.62 | 13.14 | 14.96 | 7.63 | 6.93 | 9.98 | 4.85 | 9.43 | 15.74 | 10.34 | 12.19 |
| — | -37.1% | -77.5% | -77.5% | -49.1% | -13.3% | +88.6% | +14.8% | -38.5% | +33.2% | +111.1% | +31.7% | +208.6% | -19.0% | -56.0% | -3.5% | -60.2% | +2.5% | +9.2% | -61.8% | -20.5% | |
| Quick Ratio | 4.72 | 5.55 | 6.20 | 3.39 | 4.68 | 8.81 | 27.57 | 15.08 | 9.20 | 10.16 | 14.62 | 13.14 | 14.96 | 7.63 | 6.93 | 9.98 | 4.85 | 9.43 | 15.74 | 10.34 | 12.19 |
| — | -37.1% | -77.5% | -77.5% | -49.1% | -13.3% | +88.6% | +14.8% | -38.5% | +33.2% | +111.1% | +31.7% | +208.6% | -19.0% | -56.0% | -3.5% | -60.2% | +2.5% | +9.2% | -61.8% | -20.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | -182.84 | — | — | — | -10.07 | — | — | — | -33.81 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 36 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RKTO stock.
Rocket One Inc.'s current P/E is -0.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Rocket One Inc.'s business trajectory between earnings reports.